Home › Heart Failure › New York › Greenburgh
Heart Failure clinical trials in Greenburgh, NY
3 studies for Heart Failure are looking for participants at sites in and around Greenburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
Recruiting
- Westchester Medical Center, Valhalla · 5 mi away
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
RecruitingObservational study
- WMCHealth Advanced Physician Services, Valhalla · 5 mi away
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RecruitingPhase 3
- Westchester Medical Center, Valhalla · 5 mi away
About Heart Failure
Heart failure, or congestive heart failure (CHF), means the heart can't pump enough blood. Learn about the signs, symptoms, and causes.
More about Heart Failure on MedlinePlus
Heart Failure trials in other cities
- New York City, NY51 studies
- Boston, MA46 studies
- Dallas, TX42 studies
- Houston, TX35 studies
- Cleveland, OH31 studies
- Philadelphia, PA31 studies
- San Francisco, CA29 studies
- Chicago, IL28 studies
- Durham, NC25 studies
- Kansas City, MO25 studies
- St. Louis, MO24 studies
- Indianapolis, IN24 studies
Other studies in Greenburgh
- Breast Cancer45 studies
- Non-Small Cell Lung Cancer30 studies
- Lung Cancer18 studies
- Prostate Cancer17 studies
- Acute Myeloid Leukemia17 studies
- Cancer (all types)16 studies
- Multiple Myeloma13 studies
- Colorectal Cancer12 studies
- Endometrial Cancer12 studies
- Bladder Cancer11 studies
- Metastatic Cancer11 studies
- Lymphoma9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.